AI for Global Health: From Product Development to Policy

Artificial intelligence is moving rapidly from research labs into the hands of community health workers, clinics, and public health programmes that shape outcomes for billions of people. But, how do we know a product is ready for deployment – and who gets to decide?

This event, brought to you by K4DD, takes stock of where AI is shifting the dial in global health, and where the hype outpaces the evidence. AI-enabled tools are being piloted across triage, diagnostics, health worker support and patient engagement, while questions about data, equity, clinical safety and governance have moved to the centre of the policy conversation.

The session brings together practitioners, researchers, funders and regulators to move from foundations to frontline evidence. Following opening remarks from FCDO, Audere will deliver an “AI 101” for global health audiences, followed by a real-world clinical trial case study from the London School of Hygiene and Tropical Medicine and a fireside chat with the Gates Foundation on what rigorous evidence generation looks like in practice. The session will close with reflections from an African regulatory leader (TBC) and a Q&A session moderated by PATH.

The webinar will also mark the launch of a new K4DD guide on how to assess AI4health programmes – a practical framework to help policymakers, funders and programme managers evaluate AI-enabled health interventions. The guide offers a practical framework for interrogating claims, weighing evidence, and asking the right questions about safety, equity, performance, and value for money.  It will be available on the K4DD website soon.

This event aims to support more evidence-based, context-relevant approaches to deploying, evaluating and governing AI in global health.

Speakers:

• Kerry Millington, Global Health Researcher, Liverpool School of Tropical Medicine and K4DD
• Meena Gandhi, Health Head of Profession, Research and Evidence Directorate, Foreign, Commonwealth and Development Office
• Dino Rech, CEO and Founder, Audere (AI 101).
• Ambrose Agweyu, Professor, London School of Hygiene and Tropical Medicine
• Melissa Miles, Senior Program Officer, Gates Foundation
• Maelle-Marie Troadec, Regulatory Fellow, PATH 
• Regulatory Leader (TBC)

When and where

• 2 June 2026
• 13:00 – 14:30 UK time
• Online – Teams Webinar